Inhibition of purine phosphoribosyltransferases from Ehrlich ascites-tumour cells by purine nucleotides.
1. The purine bases adenine, hypoxanthine and guanine were rapidly incorporated into the nucleotide fraction of Ehrlich ascites-tumour cells in vivo. 2. The reaction of 5'-phosphoribosyl pyrophosphate with adenine phosphoribosyltransferase from ascites-tumour cells (K(m) 6.5-11.9mum) was competitively inhibited by AMP, ADP, ATP and GMP (K(i) 7.5, 21.9, 395 and 118mum respectively). Similarly the reactions of 5'-phosphoribosyl pyrophosphate with both hypoxanthine phosphoribosyltransferase and guanine phosphoribosyltransferase (K(m) 18.4-31 and 37.6-44.2mum respectively) were competitively inhibited by IMP (K(i) 52 and 63.5mum) and by GMP (K(i) 36.5 and 5.9mum). 3. The nucleotides tested as inhibitors did not appreciably compete with the purine bases in the phosphoribosyltransferase reactions. 4. It was postulated that the purine phosphoribosyltransferases of Ehrlich ascites-tumour cells may be effectively separated from the adenine nucleotide pool of these cells.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000818:Animals; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D005260:Female; D005964:Glucosyltransferases / Q000378:metabolism*; D006150:Guanine Nucleotides / Q000494:pharmacology*; D007042:Hypoxanthines / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D009711:Nucleotides / Q000494:pharmacology*
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D007042:Hypoxanthines; D009711:Nucleotides; D005964:Glucosyltransferases